Back to Results
First PageMeta Content
Asthma / Respiratory therapy / Dividend / Electronic Arts / Productivity / Technology / Video game development / Business


CHAIRMAN’S AND CEO’S REPORT RECORD PROFIT, STRONG GROWTH AND 3 CENTS FULLY FRANKED INTERIM DIVIDEND Medical Developments International Ltd. (ASX:MVP) delivered a Record Net
Add to Reading List

Document Date: 2014-09-05 03:39:24

Open Document

File Size: 481,51 KB

Share Result on Facebook

City

Luxemburg / /

Company

Medical Developments International Ltd. / Glaxosmithkline plc / /

Continent

Asia / Europe / /

Country

Germany / Switzerland / Belgium / France / Austria / United States / Netherlands / Italy / Canada / Australia / United Kingdom / Singapore / United Arab Emirates / Spain / New Zealand / Denmark / /

Currency

USD / cent / /

Event

FDA Phase / Dividend Issuance / /

Facility

Royal Adelaide Hospital / /

IndustryTerm

pharmaceutical manufacturing / manufacturing efficiency / regulatory applications / /

MedicalCondition

FY10 FY11 FY12 FY13 ASTHMA / Global Asthma Co-ordinator / Asthma / /

Organization

Royal Adelaide Hospital / US Food & Drug Authority / FDA / Completed Royal Adelaide Hospital / /

Person

David Williams / /

/

Position

Business Development Manager / John Sharman Chief Executive Officer / Manager for Asthma in Europe / CHAIRMAN / Head Office / Manager / Global Asthma Co-ordinator and additional sales / Business Development Manager / Global Asthma Co-ordinator / AND CEO / /

Product

Asthma Devices / Asthma / Asthma Device / Authority Application / Hospitals / United Kingdom / /

Region

Eastern Europe / Middle East / /

Technology

GPS / /

SocialTag